An ACTH 4–9 analog (Org 2766) and cognitive performance: High-dose efficacy and safety in dementia of the Alzheimer's type

References

1. • American Psychiatric Association
   3rd Ed. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington, DC1980: 111-112
   • Google Scholar
2. • Berry S.
   • Haynes L.W.
   The opiomelanocortin peptide family: Neuronal expression and modulation of neural cellular development and regeneration in the central nervous system.
   Comp Bioch Physiol. 1989; 93: 267-272
   • Scopus (13)
   • Crossref
   • Google Scholar
3. • Branconnier R.J.
   • Cole J.O.
   The effects of Org 2766 on mild senile organic brain syndrome. Unpublished results cited by Pigache RM, Rigter H (1980): Effects of peptides related to ACTH on mood and vigilance in man.
   in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
   • Google Scholar
4. • Braverman A.
   • Hamdy R.
   • Hendrickson E.
   • Meisner P.
   • Perrera J.
   • Pigache R.M.
   Unpublished results cited by Pigache RM, Rigter H.
   in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
   • Google Scholar
5. • Buschke H.
   • Fuld P.A.
   Evaluating storage, retention, and retrieval in disordered memory and learning.
   Neurology. 1974; 24: 1019-1025
   • PubMed
   • Crossref
   • Google Scholar
6. • Ferris S.H.
   • Resiberg B.
   • Gershon S.
   Neuropeptide effects on cognition in the elderly.
   in: Poon L. Aging in the 1980's: Selected Contemporary Issues in the Psychology of Aging. American Psychological Association, Washington, DC1980
   • Google Scholar
7. • Folstein M.F.
   • Folstein S.E.
   • McHugh P.R.
   “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician.
   J Psychiatr Res. 1975; 12: 189-198
   • Scopus (71730)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
8. • Gaillard A.W.K.
   • Varey C.A.
   Some effects of an ACTH 4–9 analog (Org 2766) on human performance.
   Physiol Behav. 1979; 23: 79-84
   • Scopus (34)
   • PubMed
   • Crossref
   • Google Scholar
9. • Greven H.M.
   • De Wied D.
   The influence of peptides derived from corticotrophin on performance. Structure-activity studies.
   Progr Brain Res. 1973; 39: 429-442
   • Scopus (140)
   • PubMed
   • Crossref
   • Google Scholar
10. • Horowitz S.H.
    Therapeutic strategies in promoting peripheral nerve regeneration.
    Muscle and Nerve. 1989; 12: 314-322
    • Scopus (24)
    • PubMed
    • Crossref
    • Google Scholar
11. • Miller T.P.
    • Taylor J.L.
    • Tinklenberg J.R.
    A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.
    Neuropsychobiology. 1988; 19: 90-96
    • Scopus (59)
    • PubMed
    • Crossref
    • Google Scholar
12. • Norris H.
    The action of sedatives on brain stem oculomotor systems in man.
    Neuropharmacology. 1971; 10: 181-191
    • Scopus (338)
    • PubMed
    • Crossref
    • Google Scholar
13. • O'Hanlon J.F.
    • Fussler C.
    • Sancin E.
    • Grandjean E.P.
    Efficacy of an ACTH 4–9 analog, relative to that of a standard drug (d-amphetamine) for blocking the “vigilance decrement” in men.
    Report to Organon International. 1978; (October 1978)
    • Google Scholar
14. • Pigache R.M.
    • Rigter H.
    Effects of peptides related to ACTH on mood and vigilance in man.
    in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
    • Google Scholar
15. • Resiberg B.
    • Ferris S.
    • de Leon M.J.
    • Crook T.
    The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia (PDD).
    Am J Psychiatry. 1982; 139: 1136-1139
    • PubMed
    • Google Scholar
16. • Rosen W.
    • Mohs R.
    • Davis K.
    A new rating scale for Alzheimer's disease.
    Am J Psychiatry. 1984; 141: 1356-1364
    • PubMed
    • Google Scholar
17. • Shakow D.
    Psychological deficit in schizophrenia.
    Behavioral Science. 1963; 8: 275-305
    • Scopus (128)
    • PubMed
    • Crossref
    • Google Scholar
18. • Shakow D.
    The Worcester State Hospital research on schizophrenia (1927–1946).
    Journal of Abnormal Psychology. 1972; 80: 67-110
    • Scopus (16)
    • PubMed
    • Crossref
    • Google Scholar
19. • Strand F.L.
    • Rose K.J.
    • King J.A.
    • Segarra A.C.
    • Zuccarelli L.A.
    ACTH modulation of nerve development and regeneration.
    Prog Neurobiol. 1989; 33: 45-85
    • Scopus (91)
    • PubMed
    • Crossref
    • Google Scholar
20. • Tinklenberg J.R.
    • Taylor J.L.
    Assessments of drug effects on human memory functions.
    in: Squire L.R. Butters N. The Neuropsychology of Memory. Guildford Press, New York1984: 213-223
    • Google Scholar
21. • Tinklenberg J.R.
    • Taylor J.L.
    • Miller T.P.
    • Redington D.
    Dual task assessment of attentional capacities in aging and dementia.
    in: Gaitz C.M. Schoolar J.C. Rabinowitz H. Aging 2000: Our Health Care Destiny. Springer Publishing Co, New York1985
    • Google Scholar
22. • Van der Hoop R.G.
    • Brakkee J.H.
    • Kapelle A.
    • Samson M.
    • de Koning P.
    • Gispen W.H.
    A new approach for the evaluation of recovery after peripheral nerve damage.
    J Neurosci Methods. 1988; 26: 111-116
    • Scopus (16)
    • PubMed
    • Crossref
    • Google Scholar
23. • Willner A.
    Effects of peptides related to ACTH on mood and vigilance in man. Frontier of Hormone Research. Vol. 6. Karger, Zurich1980 (Unpublished results cited by Pigache RM, Rigter H)
    • Google Scholar